New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
Go back to New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 116.16 -0.95 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $117.11 | 52 Week High | $39.41 | |||
| Open | $117.70 | 52 Week Low | $25.98 | |||
| Day High | $118.68 | P/E | 163.61 | |||
| Day Low | $116.07 | EPS | $0.71 | |||
| Volume | 365,126 | |||||



